, Tracking Stock Market Picks
Enter Symbol:
Biomarin Pharmaceutical Inc. (BMRN) [hlAlert]

up 378.39 %

Biomarin Pharmaceutical Inc. (BMRN) rated Outperform by William Blair

Posted on: Friday,  Sep 12, 2008  8:25 AM ET by William Blair

William Blair rated Outperform Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) on 09/12/2008, when the stock price was $27.36. Since
then, Biomarin Pharmaceutical Inc. has gained 378.40% as of 11/25/2015's recent price of $130.89.
If you would have followed this William Blair's recommendation on BMRN, you would have gained 378.39% of your investment in 2630 days.

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.

The Equity Research department provides the firm's clients with in-depth investment analysis and investment recommendations. Acting as the company's laboratory for new investment ideas, it specializes in providing investment analysis on quality growth companies. Located together in our Chicago office, our equity analysts currently follow a universe of nearly 360 companies.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/12/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -3.49 %
1 Month down  -3.19 %
3 Months down  -33.11 %
1 YTD down  -30.22 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy